Pharma Journalist -

DTx Pharma, a biotechnology company addressing the delivery challenges of oligonucleotide therapeutics with its Fatty Acid Ligand Conjugated OligoNucleotides (FALCON) platform,…
Read More...

ANNEXA-I, a post-marketing Phase IV trial to assess the efficacy and safety of Andexxa (andexanet alfa) in patients on oral FXa-inhibitor treatment including apixaban and rivaroxaban…
Read More...

Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER (ferric carboxymaltose…
Read More...

Vazyme, China's leading biotechnology company, has officially signed a global strategic cooperation agreement with Azenta Life Sciences, which will promote to establish "one-stop"…
Read More...

Lotus Pharmaceuticals, a multinational pharmaceutical company, Alvogen, a privately owned U.S. based pharmaceuticals company, and NRx Pharmaceuticals Inc., a clinical stage…
Read More...

BiondVax Pharmaceuticals Ltd., a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of…
Read More...

Bayer and Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, announced an exclusive license agreement to develop and commercialize Cedilla…
Read More...

Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, announced it has acquired Synaffix B.V. (Synaffix), a biotechnology company focused on…
Read More...

InDex Pharmaceuticals Holding AB announced that a license agreement has been signed with Viatris Pharmaceutical Japan Inc. to register and commercialize cobitolimod in Japan for the…
Read More...

AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone has been approved in the US for the treatment of adult patients with deleterious…
Read More...